News/ News/ R&D Aerpio starts trial of drug for COVID blood vessel damage Phil Taylor Aerpio Pharmaceuticals, ARDS, coronavirus, COVID-19 0 Comment One of the less well-known symptoms of COVID-19 is inflammation and injury to blood vessels, and US biotech Share X Aerpio starts trial of drug for COVID blood vessel damage https://pharmaphorum.com/news/aerpio-starts-trial-of-drug-for-covid-blood-vessel-damage/
Aerpio Pharmaceuticals, ARDS, coronavirus, COVID-19
0 Comment
